Oxaliplatin 5 mg/mL
Oxaliplatin · INJECTION, SOLUTION · BluePoint Laboratories
Oxaliplatin is a platinum-based chemotherapy drug given by injection into a vein to treat colorectal cancer and certain other cancers. It works by damaging cancer cell DNA to stop tumor growth.
Key Facts
- Brand Name
- Oxaliplatin
- Generic Name
- Oxaliplatin
- NDC Code (Product)
68001-468- Manufacturer
- BluePoint Laboratories
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA204368
- Drug Class
- Platinum-based Drug [EPC]
- Marketing Start
- 12/09/2020
Recall History
Johnson Matthey Inc.
cGMP Deviations: Potential glass contamination
sanofi-aventis US, Inc.
CGMP Deviations: Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues in Good Manufacturing Practices.
sanofi-aventis US, Inc.
CGMP Deviations: Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues in Good Manufacturing Practices.
Infusion Options, Inc.
Lack of Assurance of Sterility
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Oxaliplatin used for?
Oxaliplatin is a platinum-based chemotherapy drug given by injection into a vein to treat colorectal cancer and certain other cancers. It works by damaging cancer cell DNA to stop tumor growth.
Is Oxaliplatin a controlled substance?
Oxaliplatin is not classified as a controlled substance by the DEA.
What is the generic name for Oxaliplatin?
The generic name for Oxaliplatin is Oxaliplatin. There are 1 other brand versions of Oxaliplatin.
What is the NDC code for Oxaliplatin 5 mg/mL?
The NDC (National Drug Code) for Oxaliplatin 5 mg/mL is 68001-468, listed by BluePoint Laboratories.